Cytokine response over the course of COVID-19 infection in pregnant women
- PMID: 35490452
- PMCID: PMC9035355
- DOI: 10.1016/j.cyto.2022.155894
Cytokine response over the course of COVID-19 infection in pregnant women
Abstract
Objective: To study how severity and progression of coronavirus disease (COVID-19) affect cytokine profiles in pregnant women.
Materials and methods: 69 third-trimester, pregnant women were tested for COVID-19 infection and SARS-CoV-2 specific IgM and IgG antibodies. Patients were stratified according to SARS-CoV-2 Reverse Transcriptase-PCR (RT-PCR) status and serology (IgM and IgG) status. Cytokines G-CSF, HGF, IL-18, IL-1Ra, IL-2Ra, IL-8, and IP-10 were measured via ELISA. Retrospective chart review for COVID-19 symptoms and patient vitals was conducted, and cytokine levels were compared between SARS-CoV-2 positive and negative cohorts, by seronegative and seropositive infection, by time course since onset of infection, and according to NIH defined clinical severity.
Results: IL-18, IL-1Ra, and IP-10 increased in the 44 RT-PCR positive pregnant women compared to the 25 RT-PCR negative pregnant controls. Elevated cytokine levels were found in early infections, defined by positive RT-PCR and seronegative status, and higher cytokine levels were also associated with more severe disease. By IgM seroconversion, IL-8 and IP-10 returned to levels seen in uninfected patients, while IL-18 levels remained significantly elevated.
Conclusion: Cytokine profiles of third-trimester pregnant women vary with the time course of infection and are correlated with clinical severity.
Keywords: Cytokine profile; Interferon; Interleukin; Pregnancy; SARS-CoV-2.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





References
-
- Kasper M.R., Geibe J.R., Sears C.L., Riegodedios A.J., Luse T., Von Thun A.M., McGinnis M.B., Olson N., Houskamp D., Fenequito R., Burgess T.H., Armstrong A.W., DeLong G., Hawkins R.J., Gillingham B.L. An Outbreak of Covid-19 on an Aircraft Carrier. N. Engl. J. Med. 2020;383:2417–2426. doi: 10.1056/nejmoa2019375. - DOI - PMC - PubMed
-
- White E.M., Santostefano C.M., Feifer R.A., Kosar C.M., Blackman C., Gravenstein S., Mor V. Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities. JAMA Int. Med. 2020;180:1709. doi: 10.1001/jamainternmed.2020.5664. - DOI - PMC - PubMed
-
- Zambrano L.D., Ellington S., Strid P., Galang R.R., Oduyebo T., Tong V.T., Woodworth K.R., Nahabedian J.F., Azziz-Baumgartner E., Gilboa S.M., Meaney-Delman D., Akosa A., Bennett C., Burkel V., Chang D., Delaney A., Fox C., Griffin I., Hsia J., Krause K., Lewis E., Manning S., Mohamoud Y., Newton S., Neelam V., Olsen E.O., Perez M., Reynolds M., Riser A., Rivera M., Roth N.M., Sancken C., Shinde N., Smoots A., Snead M., Wallace B., Whitehill F., Whitehouse E., Zapata L. CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020. MMWR Morb. Mortal. Wkly Rep. 2020;69(44):1641–1647. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous